Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.65 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.35 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.35 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9355139 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL585911 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL6055738 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2197196 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL4304542 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2193820 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL2196655 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL4903660 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL15419872 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 | |
| SCHEMBL3394636 | 1.00 | TRIM24 (0.65) | TRIM24TRIM33ALDH1A1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| WO-2017060437-A1 | METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE | BASF SE (DE) | 2017-04-13 | — | — | WO | claimed |
| EP-1264594-B1 | Melanin production inhibitors and skincare products containing such inhibitors | TAKASAGO PERFUMERY CO LTD (JP) | 2006-11-29 | — | — | EP | claimed |
| US-6759557-B2 | MACROCYCLIC HYDROCARBON RINGS WITH HYDROXYL AND/OR KETONE FUNCTIONALITIES, SUCH AS CYCLOTETRADECANONE OR 2-HYDROXYCYCLOHEXADECANONE, OPTIONALLY WITH SKIN WHITENING AGENTS AND/OR UV ABSORBERS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-07-06 | — | — | US | claimed |
| US-20030049213-A1 | Melanin production inhibitors and skincare products containing such inhibitors | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-03-13 | — | — | US | claimed |
| EP-1264594-A2 | Melanin production inhibitors and skincare products containing such inhibitors | Takasago International Corporation (JP) | 2002-12-11 | — | — | EP | claimed |
| CN-112004852-B | Core-shell capsules prepared with linear and cyclic aliphatic polyisocyanates | 西姆莱斯有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115701973-A | Perfume mixture containing 1- (4, 4-dimethylcyclohexen-1-yl) ethanone | 西姆莱斯有限公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-110546247-B | 4-ethyl-octene-2/3-carbonitriles as fragrances | 西姆莱斯有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115551825-A | Lilac type aromatic compound | 西姆莱斯有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115515920-A | Oxasantalene type fragrance compounds | 西姆莱斯股份公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-110099990-B | Perfume mixture | 西姆莱斯股份公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-115322833-A | Perfume mixture | 西姆莱斯股份公司 | 2022-11-11 | — | — | CN | disclosed |
| US-20050271608-A1 | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives | GUPTA SHYAM K | 2005-12-08 | — | — | US | disclosed |
| US-6776803-B2 | Hair dye compositions | KAO CORPORATION (JP) | 2004-08-17 | — | — | US | disclosed |
| US-6759557-B2 | MACROCYCLIC HYDROCARBON RINGS WITH HYDROXYL AND/OR KETONE FUNCTIONALITIES, SUCH AS CYCLOTETRADECANONE OR 2-HYDROXYCYCLOHEXADECANONE, OPTIONALLY WITH SKIN WHITENING AGENTS AND/OR UV ABSORBERS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-07-06 | — | — | US | disclosed |
| US-20030066141-A1 | Hair dye compositions | KAO CORPORATION (JP) | 2003-04-10 | — | — | US | disclosed |
| US-20030049213-A1 | Melanin production inhibitors and skincare products containing such inhibitors | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-03-13 | — | — | US | disclosed |
| EP-1264594-A2 | Melanin production inhibitors and skincare products containing such inhibitors | Takasago International Corporation (JP) | 2002-12-11 | — | — | EP | disclosed |
| EP-1238649-A2 | Hair dye compositions | Kao Corporation (JP) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030049213-A1 | Melanin production inhibitors and skincare products containing such inhibitors | TYR, AOC3, DOHH | TRIM24 444/4885TRIM33 4685/4885ALDH1A1 322/4885 |
| US-20030066141-A1 | Hair dye compositions | HAAO, SRD5A1, GLA | TRIM24 4805/4885TRIM33 4848/4885ALDH1A1 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.